Biorelate
- Company typePrivate
- Founded2014
- HeadquartersManchester, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
Biorelate firmographics
Firmographics- Name
- Biorelate
- Legal name
- Biorelate Limited
- Website
- https://biorelate.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Biorelate industry classification
Industry- Product category
- Biomedical Data Curation Software
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Software Publishers (51321), Computer Systems Design and Related Services (54151)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Computer Integrated Systems Design (7373)
- akta.pro primary industry
- Knowledge Management & Scientific Collaboration / Literature Intelligence (HLAGAJAN)
- akta.pro secondary industries
- AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO), Bioinformatics & Multi-omics Analysis Software (HLAGAJAD), Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)
Keywords
Where Biorelate is headquartered
LocationHeadquarters
- HQ city
- Manchester
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
Biorelate business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- SaaS Platform Subscriptions: B2B SaaS model offering multiple access points including Galactic Data (database access), Galactic API (RESTful API integration), Galactic Web (advanced web interface), and Galactic Platform (federated solution including third-party subscription content). Subscription-based pricing with enterprise deals.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise SaaS subscription with multiple product tiers |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels7 records
Biorelate product offering
Product offeringCore offering
Biorelate provides AI-powered biomedical data curation through its Galactic AI platform, using NLP, AI, and Large Language Models to transform unstructured biomedical literature into structured, FAIR-compliant knowledge graphs containing cause-and-effect relationships among genes, diseases, drugs, and biological entities. The platform is delivered to pharmaceutical and biotech R&D teams via multiple access points: Galactic Enterprise (flagship LLM-native intelligence platform), Galactic Data (downloadable knowledge graph datasets), Galactic Web (web interface), Galactic API (RESTful API), and Galactic Platform (federated solution with third-party content).
Product overview
Biorelate offers Galactic AI, a unified AI-powered data curation platform for biopharmaceutical research. The product portfolio consists of Galactic Enterprise as the flagship intelligence platform, supported by Galactic Data (direct knowledge graph access), Galactic Web (user interface), Galactic API (programmatic access), and Galactic Platform (federated solution incorporating third-party content). These products work together to transform unstructured biomedical literature into structured, actionable cause-and-effect relationships for drug discovery.
Differentiator
Problem solved
Functional benefit
Brands
- Galactic Enterprise: Intelligence platform leveraging the most accurate biomedical AI curation model, powered by Galactic Data 3.0
- Galactic AI
- Galactic Platform
- Galactic API
- Galactic Web
- Galactic Data
Products and services
- Galactic Enterprise Flagship intelligence platform leveraging Galactic AI for the most accurate biomedical AI curation model available in biopharma, providing human-level precision, cross-sentence causal edges, full provenance, and AI/agent readiness for RAG workflows. Targeted at enterprise biopharma R&D teams.
- Galactic Data Direct access to the most comprehensive knowledge graph in biopharma with over 3 billion entity annotations, 637+ million relationships, and cause-and-effect interaction mentions. Delivered as downloadable, FAIR-compliant data that loads directly into Neo4j or Postgres. Targeted at data scientists and computational biologists.
- Galactic Web Advanced web interface enabling scientists and researchers direct access to hard-to-find biomedical data and analytics, including detailed cause-and-effect pathways, molecular pathology insights, and target hypothesis support. Targeted at biologists and bioinformaticians.
- Galactic API RESTful API providing seamless integration with existing workflows and dashboards, facilitating efficient data processing and incorporation of Galactic AI insights directly into tools and platforms. Targeted at data scientists and enterprise integrators.
- Galactic Platform Federated solution extending Galactic AI's data curation capabilities to include third-party subscription content alongside public knowledge, providing a robust evidence base for drug target selection, hypothesis formulation, biomarker identification, and indication expansion. Targeted at enterprise biopharma R&D and information managers.
Quantifiable outcome
- 5x faster reach to explainable, actionable results
- +7 more outcomes
Companies that use Biorelate
Customer profileNamed customers14 records
Segments4 records
Ideal customer profiles3 records
Biorelate technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability6 records
Feature8 records
Biorelate partnerships and signals
Strategic signalScale indicators11 records
Recent moves6 records
Expansion highlights7 records
Biorelate competitors and assessment
Company assessmentBroad incumbents
- Owkin: Owkin applies AI to biomedical and clinical data for drug discovery and development, with overlapping customer segments in pharma R&D; competes for the same enterprise data-curation and AI-platform budgets as Biorelate.
- BenevolentAI: BenevolentAI is an established AI drug discovery company that combines biomedical knowledge graphs with ML to identify novel targets — a broader incumbent in the same AI-for-pharma category as Biorelate but with a wider therapeutic pipeline focus.
- Tempus Labs: Tempus operates a large-scale AI-powered biomedical data platform spanning clinical and molecular data; overlaps with Biorelate in serving pharma customers with curated data assets for R&D decision-making, though broader in scope.
- Recursion Pharmaceuticals: Recursion is an AI-driven drug discovery company combining high-throughput biology with ML models, targeting similar pharma R&D buyers; competes for enterprise AI-in-R&D budget and represents a much larger incumbent in the space.
- Insitro: Insitro combines ML with biological data for drug discovery and is a broader AI-for-pharma incumbent targeting similar pharma partnerships and platform-style relationships that Biorelate pursues.
- Elsevier (RELX): Elsevier owns biomedical databases such as Embase and Reaxys and has been expanding into AI-enabled literature analytics, overlapping with Biorelate's mission to structure biomedical literature for R&D but as a global publishing incumbent.
- Clarivate: Clarivate provides scientific and intellectual property research intelligence including literature analytics and knowledge tools for life sciences, overlapping with Biorelate's literature intelligence positioning at much larger scale.
Direct peers
- Causaly: Causaly is an AI platform for biomedical knowledge discovery that builds cause-and-effect knowledge graphs from scientific literature, directly overlapping with Biorelate's core Galactic AI curation offering for pharma R&D target identification and indication expansion.
- SciBite (Elsevier): SciBite provides AI-driven biomedical text analytics, named entity recognition, and ontology-led data curation for life sciences — directly comparable to Biorelate's NLP-based curation pipelines serving pharma and biotech customers.
- Linguamatics (IQVIA): Linguamatics, an IQVIA company, provides AI-based biomedical text mining for pharma and healthcare, directly comparable to Biorelate's NLP-driven literature curation and target/disease relationship extraction use cases.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Biorelate social profiles
Digital presenceBiorelate compliance and trust
Trust signalCompliance1 record
Biorelate financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biorelate leadership team
Management profileNumber of profiles
Profiles9 records
Biorelate funding detail
Funding detailFunding overview
Funding rounds3 records
Investors8 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biorelate M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biorelate
What does Biorelate do?
Biorelate provides AI-powered biomedical data curation through its Galactic AI platform, using NLP, AI, and Large Language Models to transform unstructured biomedical literature into structured, FAIR-compliant knowledge graphs containing cause-and-effect relationships among genes, diseases, drugs, and biological entities. The platform is delivered to pharmaceutical and biotech R&D teams via multiple access points: Galactic Enterprise (flagship LLM-native intelligence platform), Galactic Data (downloadable knowledge graph datasets), Galactic Web (web interface), Galactic API (RESTful API), and Galactic Platform (federated solution with third-party content).
Is Biorelate a public or private company?
Biorelate is a private company. It is classified as venture growth investor backed and is currently operating.
When was Biorelate founded?
Biorelate was founded in 2014. It employs 11 to 50 people.
Where is Biorelate based?
Biorelate is headquartered in Manchester, United Kingdom, in the Europe region.
How does Biorelate make money?
One revenue line is on record: saaS Platform Subscriptions.
Who are Biorelate's main competitors?
Broad incumbents on record are Owkin, BenevolentAI, Tempus Labs, Recursion Pharmaceuticals, Insitro, Elsevier (RELX) and Clarivate. Direct peers are Causaly, SciBite (Elsevier) and Linguamatics (IQVIA).
Does Biorelate have an API?
Yes. Galactic API enables seamless integration with existing workflows and dashboards through a RESTful API, facilitating the incorporation of Galactic AI insights directly into tools and platforms. It provides fully provisioned access to an extensive database of cause-and-effect relationships designed to enrich knowledge graphs and enhance data-driven decision-making.
What industry is Biorelate in?
Biorelate's product category is Biomedical Data Curation Software. Its primary akta.pro industry code is HLAGAJAN, Knowledge Management & Scientific Collaboration / Literature Intelligence, with a secondary code of HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization. Its NAICS code is 541714 and its SIC code is 8731.